Articles

Overview Of Changes in Information Security and Personal Data Protection Affecting Wholesale and Retail Trade of Medicinal Products in Russia

Published 21 July 2025 Lidings, Russia

Key updates in Russian data security & healthcare CII: New rules for personal data consent (effective Sept 2025), healthcare CII categorization, and penalties for non-compliance. Essential for pharma & medical retailers

... Read more

Procurement of medical devices: New measures between the EU and China

Published 11 July 2025 by William Timmermans. ALTIUS Lawyers, Belgium

On 30 June 2025, several measures entered into force that were imposed by the European Commission regarding the purchase of medical equipment originating from China.

The following two measures apply…

... Read more

Category Captains beware!: Belgian competition authority fines Category Management of OTC medicines

Published 05 June 2025 by Carmen Verdonck. ALTIUS Lawyers, Belgium

On 24 April 2025, the Belgian Competition Authority (BCA) announced a landmark decision imposing fines totaling over €11.2 million on three major pharmaceutical companies for their involvement in a long-running anti-competitive arrangement concerning the placement of over-the-counter (OTC) medicines in Belgian pharmacies. This decision is the first of its kind in the EU, setting a precedent for future competition law enforcement in category management practices.

... Read more

CJEU’s DocMorris Ruling: where is the line for pharmaceutical advertising?

Published 13 May 2025 by Kirian Claeyé. ALTIUS Lawyers, Belgium

The intersection of pharmaceutical advertising, consumer protection, and internal market freedoms remains a complex legal battleground within the EU. In Apothekerkammer Nordrhein v. DocMorris NV (C-517/23), the Court of Justice of the European Union (CJEU) revisited the meaning of ‘advertising of medicinal products’, clarifying how far national restrictions on pharmaceutical advertisements can go under EU pharmaceutical law and internal market principles.

... Read more

Compliance with the SmPC and the Presentation of Non-Registration Studies in Advertising

Published 12 May 2025 by Kateřina Slavíková. HAVEL & PARTNERS | Czech Republic, Czech Republic

Informing healthcare professionals about the latest findings from studies related to medicinal products is crucial for ensuring effective and safe patient care. Access to the most recent scientific knowledge allows physicians to better understand the effects and potential side effects of medications, leading to more informed prescribing decisions.

... Read more
1 2 3 4 5 13